Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Mosquito Adaptation to the Extreme Habitats of Urban Construction Sites.

Wilke ABB, Caban-Martinez AJ, Ajelli M, Vasquez C, Petrie W, Beier JC.

Trends Parasitol. 2019 Aug;35(8):607-614. doi: 10.1016/j.pt.2019.05.009. Epub 2019 Jun 20. Review.

2.

Community Composition and Year-round Abundance of Vector Species of Mosquitoes make Miami-Dade County, Florida a Receptive Gateway for Arbovirus entry to the United States.

Wilke ABB, Vasquez C, Medina J, Carvajal A, Petrie W, Beier JC.

Sci Rep. 2019 Jun 19;9(1):8732. doi: 10.1038/s41598-019-45337-2.

3.

Tire shops in Miami-Dade County, Florida are important producers of vector mosquitoes.

Wilke ABB, Vasquez C, Petrie W, Beier JC.

PLoS One. 2019 May 20;14(5):e0217177. doi: 10.1371/journal.pone.0217177. eCollection 2019.

4.

Localized Control of Aedes aegypti (Diptera: Culicidae) in Miami, FL, via Inundative Releases of Wolbachia-Infected Male Mosquitoes.

Mains JW, Kelly PH, Dobson KL, Petrie WD, Dobson SL.

J Med Entomol. 2019 Sep 3;56(5):1296-1303. doi: 10.1093/jme/tjz051.

PMID:
31008514
5.

Assessment of the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure for the surveillance of vector mosquitoes in Miami-Dade County, Florida.

Wilke ABB, Carvajal A, Medina J, Anderson M, Nieves VJ, Ramirez M, Vasquez C, Petrie W, Cardenas G, Beier JC.

PLoS One. 2019 Feb 22;14(2):e0212688. doi: 10.1371/journal.pone.0212688. eCollection 2019.

6.

Construction sites in Miami-Dade County, Florida are highly favorable environments for vector mosquitoes.

Wilke ABB, Vasquez C, Petrie W, Caban-Martinez AJ, Beier JC.

PLoS One. 2018 Dec 20;13(12):e0209625. doi: 10.1371/journal.pone.0209625. eCollection 2018.

7.

The Role of Pharmacogenetic Testing in the Amelioration of Antidepressant-Related Motor Disturbances in 2 Young Adult Men With Major Depressive Disorder.

Rhea KH, Petrie WM, Gardner KR.

Prim Care Companion CNS Disord. 2015 Jan 8;17(1). doi: 10.4088/PCC.14br01723. eCollection 2015.

8.

G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth.

Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ, Prossnitz ER.

Obstet Gynecol Int. 2013;2013:472720. doi: 10.1155/2013/472720. Epub 2013 Nov 27.

9.

Diet-induced metabolic change induces estrogen-independent allometric mammary growth.

Berryhill GE, Gloviczki JM, Trott JF, Aimo L, Kraft J, Cardiff RD, Paul CT, Petrie WK, Lock AL, Hovey RC.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16294-9. doi: 10.1073/pnas.1210527109. Epub 2012 Sep 17.

10.

Successful suppression of a field mosquito population by sustained release of engineered male mosquitoes.

Harris AF, McKemey AR, Nimmo D, Curtis Z, Black I, Morgan SA, Oviedo MN, Lacroix R, Naish N, Morrison NI, Collado A, Stevenson J, Scaife S, Dafa'alla T, Fu G, Phillips C, Miles A, Raduan N, Kelly N, Beech C, Donnelly CA, Petrie WD, Alphey L.

Nat Biotechnol. 2012 Sep;30(9):828-30. doi: 10.1038/nbt.2350. No abstract available.

PMID:
22965050
11.

Differential downregulation of e-cadherin and desmoglein by epidermal growth factor.

Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG.

Dermatol Res Pract. 2012;2012:309587. doi: 10.1155/2012/309587. Epub 2012 Jan 16.

12.

Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.

Trott JF, Schennink A, Petrie WK, Manjarin R, VanKlompenberg MK, Hovey RC.

J Anim Sci. 2012 May;90(5):1674-86. doi: 10.2527/jas.2011-4682. Epub 2011 Dec 28. Review.

PMID:
22205663
13.

Field performance of engineered male mosquitoes.

Harris AF, Nimmo D, McKemey AR, Kelly N, Scaife S, Donnelly CA, Beech C, Petrie WD, Alphey L.

Nat Biotechnol. 2011 Oct 30;29(11):1034-7. doi: 10.1038/nbt.2019.

PMID:
22037376
14.

Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity.

Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER.

J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):358-66. doi: 10.1016/j.jsbmb.2011.07.002. Epub 2011 Jul 14.

15.

A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.

Petrie WK, Hovey RC.

Breast Cancer Res. 2011 Jan 28;13(1):301. doi: 10.1186/bcr2802.

16.

Reintroduction of Aedes aegypti into Grand Cayman.

Wheeler AS, Petrie WD, Malone D.

J Am Mosq Control Assoc. 2009 Sep;25(3):260-4.

PMID:
19852214
17.

Introduction, control, and spread of Aedes albopictus on Grand Cayman Island, 1997-2001.

Wheeler AS, Petrie WD, Malone D, Allen F.

J Am Mosq Control Assoc. 2009 Sep;25(3):251-9.

PMID:
19852213
18.

In vivo effects of a GPR30 antagonist.

Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER.

Nat Chem Biol. 2009 Jun;5(6):421-7. doi: 10.1038/nchembio.168.

19.

An overview of Aedes aegypti and Aedes albopictus control in the British Overseas Territory of the Cayman Islands.

Wheeler AW, Petrie WD.

Euro Surveill. 2007 Nov 22;12(11):E071122.3. Review. No abstract available.

20.

Research review of the supportive care needs of spouses of women with breast cancer.

Petrie W, Logan J, DeGrasse C.

Oncol Nurs Forum. 2001 Nov-Dec;28(10):1601-7. Review.

PMID:
11759307
21.

A mobile screening unit, practicalities and problems.

McEwan SR, Arthur P, Scott A, Petrie W, Forbes CD.

Scott Med J. 1999 Aug;44(4):106-10.

PMID:
10533208
22.

Olfactory dysfunction discriminates Alzheimer's dementia from major depression.

Solomon GS, Petrie WM, Hart JR, Brackin HB Jr.

J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):64-7.

PMID:
9547468
23.

Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.

Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dubé S, Small JG.

Biol Psychiatry. 1995 Nov 1;38(9):592-602.

PMID:
8573661
24.

Effects of phosphatidylserine in Alzheimer's disease.

Crook T, Petrie W, Wells C, Massari DC.

Psychopharmacol Bull. 1992;28(1):61-6.

PMID:
1609044
25.

Effects of phosphatidylserine in age-associated memory impairment.

Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC.

Neurology. 1991 May;41(5):644-9.

PMID:
2027477
26.

Treatment of age-associated memory impairment with guanfacine.

McEntee WJ, Crook TH, Jenkyn LR, Petrie W, Larrabee GJ, Coffey DJ.

Psychopharmacol Bull. 1991;27(1):41-6.

PMID:
1862205
27.

Vitamins in psychiatry. Do they have a role?

Petrie WM, Ban TA.

Drugs. 1985 Jul;30(1):58-65. Review.

PMID:
3896744
28.

The Standard Immunisation Recall System: should it be adopted now or in the future?

Petrie W, Womersley J.

Health Bull (Edinb). 1985 Jul;43(4):167-71. No abstract available.

PMID:
3839770
29.

Alzheimer's disease.

Petrie WM.

Compr Ther. 1985 Jul;11(7):38-43.

PMID:
2863031
30.

Psychoses with propranolol: a case report.

Prakash R, Campbell TW, Petrie WM.

Can J Psychiatry. 1983 Dec;28(8):657-8.

PMID:
6661717
31.

Cholinergic effects on arousal and cocaine-induced olfactory-amygdala spindling and seizures in cats.

Castellani S, Ellinwood EH Jr, Kilbey MM, Petrie WM.

Physiol Behav. 1983 Oct;31(4):461-6.

PMID:
6657767
32.

Drug treatment of anxiety and agitation in the aged.

Petrie WM.

Psychopharmacol Bull. 1983 Spring;19(2):238-46. Review. No abstract available.

PMID:
6135237
33.

Psychiatric changes associated with an excess of folic acid.

Prakash R, Petrie WM.

Am J Psychiatry. 1982 Sep;139(9):1192-3.

PMID:
7114317
34.

Violence in geriatric patients.

Petrie WM, Lawson EC, Hollender MH.

JAMA. 1982 Jul 23;248(4):443-4.

PMID:
7087144
35.

Thyrotoxicosis presenting as depression.

Folks DG, Petrie WM.

Br J Psychiatry. 1982 Apr;140:432-3. No abstract available.

PMID:
7093625
36.

Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.

Petrie WM, Ban TA, Berney S, Fujimori M, Guy W, Ragheb M, Wilson WH, Schaffer JD.

J Clin Psychopharmacol. 1982 Apr;2(2):122-6. No abstract available.

PMID:
7042770
37.

Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.

Petrie WM, Ban TA, Wilson WH, Jamieson RC, Guy W.

Int Pharmacopsychiatry. 1982;17(4):280-6.

PMID:
7185772
38.

Propranolol and depression.

Petrie WM, Maffucci RJ, Woosley RL.

Am J Psychiatry. 1982 Jan;139(1):92-4.

PMID:
7055283
39.

Carbamazepine treatment of selected affectively disordered inpatients.

Folks DG, King LD, Dowdy SB, Petrie WM, Jack RA, Koomen JC, Swenson BR, Edwards P.

Am J Psychiatry. 1982 Jan;139(1):115-7. No abstract available.

PMID:
7055253
40.

A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.

Guy W, Ban TA, McEvoy JP, Petrie WM, Wilson WH, Schaffer JD.

Int Pharmacopsychiatry. 1982;17(1):36-42.

PMID:
7045017
41.

Systematic studies with amoxapine, a new antidepressant.

Ban TA, Fujimori M, Petrie WM, Ragheb M, Wilson WH.

Int Pharmacopsychiatry. 1982;17(1):18-27.

PMID:
7045016
42.

A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients.

Brannen JO, McEvoy JP, Wilson WH, Petrie WM, Ban TA, Berney SA, Schaffer JD.

Pharmacopsychiatria. 1981 Jul;14(4):139-40. No abstract available.

PMID:
6116246
43.

Propranolol in organic agitation.

Petrie WM, Ban TA.

Lancet. 1981 Feb 7;1(8215):324. No abstract available.

PMID:
6109956
44.

The effects of amoxapine and ethanol on psychomotor skills related to driving: a placebo and standard controlled study.

Wilson WH, Petrie WM, Ban TA, Barry DE.

Prog Neuropsychopharmacol. 1981;5(3):263-70. No abstract available.

PMID:
7267843
45.

The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.

Petrie WM, Ban TA, Ananth JV.

Int Pharmacopsychiatry. 1981;16(4):245-50.

PMID:
7040274
46.

Psychopharmacology for the elderly.

Petrie WM, Ban TA.

Prog Neuropsychopharmacol. 1981;5(4):335-42. Review. No abstract available.

PMID:
6119714
47.

PCP.

Hudson SW, Petrie WM.

South Med J. 1980 Dec;73(12):1557-8. No abstract available.

PMID:
7444540
48.

Compulsive water drinking treated with high dose propranolol.

Shevitz SA, Jameison RC, Petrie WM, Crook JE.

J Nerv Ment Dis. 1980 Apr;168(4):246-8.

PMID:
7365485
49.

Acute effects of viloxazine HCl and flurazepam when given alone and in combination on sleep EEG: a double-blind interaction study with normals.

Wilson WH, Freemon FR, Ban TA, Petrie WM, Clinton CL.

Pavlov J Biol Sci. 1980 Apr-Jun;15(2):68-73.

PMID:
7003517
50.

Possible lack of anticholinergic effects with mianserin: a pilot study.

Wilson WH, Petrie WM, Ban TA.

J Clin Psychiatry. 1980 Feb;41(2):63-5.

PMID:
7354012

Supplemental Content

Loading ...
Support Center